Nausea, vomiting, diarrhea, and constipation all increase more steeply at higher doses
NICE technology appraisal guidance (TA875) recommends semaglutide 2.4mg for adults with a BMI of 35 kg/m or greater, or 30 kg/m or greater with at least one weight-related comorbidity, when provided alongside a reduced-calorie diet and increased physical activity
Primary outcomes, energy expenditure and substrate utilization, were measured before and for 6 h after ingestion of the liquid test meal, using a ventilated hood system (Omnical, Maastricht University, The Netherlands) 47
[DOI] [PMC free article] [PubMed] [Google Scholar] 107.Lafferty R.A., O'Harte F.P.M., Irwin N., Gault V.A., Flatt P.R
(1997) examined the possibility that high short-term exposures might be responsible but found there was no evidence for this
The Functional Medicine Lens In the functional medicine paradigm , the triad of excess weight, diabetes, and GLP-1 therapy is not a story of failure it is a story of system signals, adaptation, and opportunity